Crouse Health Online: Wellness is just a click away.
  |  Connect with Us: 
Text Size

Crouse Offers New Bioabsorbable Cardiac Stent Option


Battaglia-StentCrouse is the first hospital in the area to make commercially available the Synergy cardiac stent from Boston Scientific, which features a bioabsorbable polymer drug that promotes faster arterial healing and fewer complications for those with coronary artery disease.

The SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System received FDA approval in late 2015. Both the drug coating and the polymer, which modulates drug release, are fully absorbed shortly after drug elution is complete three to four months following implantation, leaving behind a bare platinum-chromium stent.

“This stent is a major advancement for interventional cardiology,” says Joseph Battaglia, MD, medical director for cardiac services at Crouse. “It has been specifically designed to promote faster, more complete healing of the arteries while decreasing the chance for complications commonly associated with long-term polymer exposure.”

Bare metal stents and drug-eluting stents are implanted by interventional cardiologists inside the heart’s arteries to open clogged arteries and restore blood flow. Drug-eluting stents are coated with medicine that significantly reduces re-stenosis and re-vascularization procedures.

While existing stents reduce coronary stenosis, the polymer stays on the stent after the drug is delivered. Long-term exposure to the polymer may cause inflammation, which delays healing and has been associated with complications, including clot formation inside the stent, according to Dr. Battaglia

Watch Video Icon

Cardiac Care at Crouse

The Diane and Bob Miron Cardiac Care Center at Crouse Hospital provides comprehensive interventional and diagnostic care for virtually every type of adult and pediatric heart disorder, including cardiac catheterization, echocardiography/ECG studies and electrophysiology services. Crouse is also home to the region’s only pediatric cardiac catheterization program. In addition, Crouse’s door-to-cardiac intervention times are among the lowest in the state and country.




Cheryl Abrams
Crouse Hospital
Communications Department
Phone: 315/470-7123
Fax: 315/470-7232